Cogent Biosciences(COGT)

12.88 0.28 2.2222%

今开:12.32昨收:12.6
最高:12.88 最低:12.32
涨停价:0.0跌停价:0.0
总市值:9.0022743E8

Cogent Biosciences的热门评论

chuminhua06-11 11:42

6月10日,Cogent Biosciences 的股价上涨了 78%,此前该公司报告了强效、选择性 KIT D816V 抑制剂bezuclastinib用于晚期系统性肥大细胞增多症患者中治疗的 II 期试验的“积极”初步数据。
截至 5 月 24 日的数据截止日期,该开放标签试验已经在四个剂量水平中的1个治疗了 11 名患者。两名患者...查看全文

季度财报

Cogent Biosciences(COGT)11-14 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)11-14 20:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:37

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)10-05 04:42

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)09-07 04:36

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)08-09 19:21

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接查看全文

季度财报

Cogent Biosciences(COGT)08-09 19:42

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接查看全文

超过5%股东持股披露

Cogent Biosciences(COGT)07-09 05:06

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)07-06 01:57

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的最新评论

季度财报

Cogent Biosciences(COGT)05-10 20:33

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-019089 Act: 34 Size: 5 MB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)05-10 19:36

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-019075 Act: 34 Size: 406 KB 网页链接查看全文

增发股票注册声明

Cogent Biosciences(COGT)05-07 05:33

$Cogent Biosciences(COGT)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-22-143829 Act: 33 Size: 853 KB 网页链接查看全文

招股信息更正说明

Cogent Biosciences(COGT)05-07 04:36

$Cogent Biosciences(COGT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-22-143704 Act: 33 Size: 20 KB 网页链接查看全文

当期报告

Cogent Biosciences(COGT)05-07 04:33

$Cogent Biosciences(COGT)$ 8-K Current report, item 1.02 Accession Number: 0001193125-22-143689 Act: 34 Size: 149 KB 网页链接查看全文

其他

Cogent Biosciences(COGT)04-26 20:36

$Cogent Biosciences(COGT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-118978 Act: 34 Size: 680 KB 网页链接查看全文

股东委托书协议

Cogent Biosciences(COGT)04-26 20:33

$Cogent Biosciences(COGT)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-22-118969 Act: 34 Size: 805 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)04-06 04:12

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-013702 Size: 9 KB 网页链接查看全文

持股变动声明

Cogent Biosciences(COGT)04-06 04:12

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-013710 Size: 9 KB 网页链接查看全文

员工持股计划

Cogent Biosciences(COGT)03-18 04:12

$Cogent Biosciences(COGT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-22-078297 Act: 33 Size: 92 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Cogent Biosciences的新闻

Cogent Biosciences(COGT)宣布发行1.25亿美元的普通股

Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动,以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接

Cogent Biosciences的公告

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接

季度财报

$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-015760 Act: 34 Size: 6 MB 网页链接

当期报告

$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-015744 Act: 34 Size: 489 KB 网页链接

超过5%股东持股披露

$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-010347 Act: 34 Size: 12 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024929 Size: 5 KB 网页链接

持股变动声明

$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-024930 Size: 5 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20